Major depressive disorder ... remit following adequate antidepressant treatment, while most MDD patients suffer from significant core depressive or residual symptoms during their clinical course.
de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
A cutting-edge technology, magnetogenetics, now allows the inhibition or activation of brain circuits in mice remotely, without implants. Scientists at Rockefeller ... By allowing precise control of ...
For example, Medicaid, which covers 85 million Americans, could play a major role in setting demand for the treatment, as nearly 20% of Medicaid beneficiaries have clinical depression.